SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dipna Pharmachem informs about outcome of board meeting

08 Dec 2023 Evaluate
Dipna Pharmachem has informed that meeting of the Board of Directors of the Company held today, Friday, 8th December, 2023 at the Registered Office of the Company which commenced at 11:00 AM and concluded at 12:00 PM, Considered and approved increase in Authorised Share Capital up to Rs. 25,00,00,000 (Rupees Twenty-Five Crores Only) by alteration of the capital clause in the Memorandum of Association of the Company; Decided to hold Extra-Ordinary General Meeting (EGM) of the Shareholders of the Company on Wednesday, 3rd January, 2024 at 12:00 PM.

The above information is a part of company’s filings submitted to BSE.

Dipna Pharma. Share Price

9.17 -0.66 (-6.71%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×